Literature DB >> 11021002

Hypovolemia and hypovolemic shock in children with nephrotic syndrome.

S J Wang1, Y K Tsau, F L Lu, C H Chen.   

Abstract

Hypovolemic shock is not an uncommon presentation in nephrotic syndrome, yet it is seldom mentioned in the literature. This study was performed to investigate the prevalence of hypovolemia and hypovolemic shock in the acute nephrotic stage, and the association of hemoconcentration and abdominal pain with hypovolemic status. Two hundred and twenty-five patients with a total of 328 admissions to the pediatric ward of our hospital during 1983 to 1996 were retrospectively reviewed for hypovolemic episodes. Clinical presentation and laboratory data including hemoglobin, serum sodium, albumin, cholesterol, and triglyceride levels were investigated. Thirteen patients with 19 episodes (5.8%) of hypovolemic shock were found, and had more severe hemoconcentration (hemoglobin 19.6 +/- 2.2 g/dL) and hyponatremia (127.3 +/- 7.2 mEq/L). Another 33 patients with 41 symptomatic hypovolemic episodes without hypotension (12.5%) were found, and their hemoglobin levels were higher compared to patients without hypovolemic symptoms. Among 61 episodes of abdominal pain and hemoconcentration, 58 were responsive to albumin infusion. This suggested the presence of hypovolemia. Twenty patients had abdominal pain without hemoconcentration, and 18 of them had primary peritonitis. Hypovolemia was found in patients at the acute nephrotic stage, and was usually associated with hemoconcentration and abdominal pain. A combined examination of hemoglobin and serum sodium is the best indicator of hypovolemic status. Both primary peritonitis and hypovolemic episodes should be taken into consideration when managing abdominal pain in children with nephrotic syndrome.

Entities:  

Mesh:

Year:  2000        PMID: 11021002

Source DB:  PubMed          Journal:  Acta Paediatr Taiwan        ISSN: 1608-8115


  9 in total

1.  Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy.

Authors:  Yoshitsugu Kaku; Yasufumi Ohtsuka; Yasuhiro Komatsu; Toshiyuki Ohta; Takuhito Nagai; Hiroshi Kaito; Shuji Kondo; Yohei Ikezumi; Seiji Tanaka; Shinsuke Matsumoto; Mayumi Sako; Kazushi Tsuruga; Koichi Nakanishi; Koichi Kamei; Hiroshi Saito; Shuichiro Fujinaga; Yuko Hamasaki; Hiroko Chikamoto; Kenji Ishikura; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2015-02       Impact factor: 2.801

Review 2.  Body fluid dynamics: back to the future.

Authors:  Gautam Bhave; Eric G Neilson
Journal:  J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 10.121

3.  Pulmonary thrombosis in steroid-sensitive nephrotic syndrome.

Authors:  Pankaj V Deshpande; Mark Griffiths
Journal:  Pediatr Nephrol       Date:  2005-03-19       Impact factor: 3.714

4.  Syncope as initial symptom for nephrotic syndrome: a case report.

Authors:  Xuemei Wu; Guangliang Wang; Jiachun Feng
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Over- or underfill: not all nephrotic states are created equal.

Authors:  Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2013-03-26       Impact factor: 3.714

6.  Clinicopathological features and prognosis of Chinese children with idiopathic nephrotic syndrome between different age groups.

Authors:  Jei-Wen Chang; Hsin-Lin Tsai; Hsin-Hui Wang; Ling-Yu Yang
Journal:  Eur J Pediatr       Date:  2008-12-20       Impact factor: 3.183

7.  Primary peritonitis in children with nephrotic syndrome: results of a 5-year multicenter study.

Authors:  Nermin Uncu; Mehmet Bülbül; Nurdan Yildiz; Aytul Noyan; Cemlettin Koşan; Salih Kavukçu; Salim Calişkan; Zübeyde Gündüz; Nesrin Beşbaş; Ayfer Gür Güven
Journal:  Eur J Pediatr       Date:  2009-05-09       Impact factor: 3.183

8.  Complications of nephrotic syndrome.

Authors:  Se Jin Park; Jae Il Shin
Journal:  Korean J Pediatr       Date:  2011-08-31

9.  Are oxidized low-density lipoprotein and C-reactive protein markers of atherosclerosis in nephrotic children?

Authors:  A Rybi-Szumińska; A Wasilewska; J Michaluk-Skutnik; B Osipiuk-Remża; R Fiłonowicz; M Zając
Journal:  Ir J Med Sci       Date:  2014-07-24       Impact factor: 1.568

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.